Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2017

Open Access 01-12-2017 | Research

The role of total cell-free DNA in predicting outcomes among trauma patients in the intensive care unit: a systematic review

Authors: Mikail Gögenur, Jakob Burcharth, Ismail Gögenur

Published in: Critical Care | Issue 1/2017

Login to get access

Abstract

Background

Cell-free DNA has been proposed as a means of predicting complications among severely injured patients. The purpose of this systematic review was to assess whether cell-free DNA was useful as a prognostic biomarker for outcomes in trauma patients in the intensive care unit.

Methods

We searched Pubmed, Embase, Scopus and the Cochrane Central Register for Controlled Trials and reference lists of relevant articles for studies that assessed the prognostic value of cell-free DNA detection in trauma patients in the intensive care unit. Outcomes of interest included survival, posttraumatic complications and severity of trauma. Due to considerable heterogeneity between the included studies, a checklist was formed to assess quality of cell-free DNA measurement.

Results

A total of 14 observational studies, including 904 patients, were eligible for analysis. Ten studies were designed as prospective cohort studies; three studies included selected patients from a cohort while one study was of a retrospective design. We found a significant correlation between higher values of cell-free DNA and higher mortality. This significant correlation was evident as early as on intensive care unit admission. Likewise, cell-free DNA predicted the severity of trauma and posttraumatic complications in a majority of patients.

Conclusion

The amount of cell-free DNA can function as a prognostic tool for mortality and to a lesser extent severity of trauma and posttraumatic complications. Standardizing cell-free DNA measurement is paramount to ensure further research in cell-free DNA as a prognostic tool.
Appendix
Available only for authorised users
Literature
1.
Kim K, Shin DG, Park MK, Baik SH, Kim TH, Kim S, Lee S. Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection. Ann Surg Treat Res. 2014;86:136–42.CrossRefPubMedPubMedCentral
2.
Szpechcinski A, Chorostowska-Wynimko J, Struniawski R, Kupis W, Rudzinski P, Langfort R, Puscinska E, Bielen P, Sliwinski P, Orlowski T. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease. Br J Cancer. 2015;113:476–83.CrossRefPubMedPubMedCentral
3.
Reinert T, Scholer LV, Thomsen R, Tobiasen H, Vang S, Nordentoft I, Lamy P, Kannerup AS, Mortensen FV, Stribolt K, Hamilton-Dutoit S, Nielsen HJ, Laurberg S, Pallisgaard N, Pedersen JS, Orntoft TF, Andersen CL. Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery. Gut. 2016;65:625–34.CrossRefPubMed
4.
Norton M, Jacobsson B, Swamy G, Laurent L, Ranzini A, Brar H, Tomlinson M, Pereira L, Spitz J, Hollemon D, Cuckle H, Musci T, Wapner R. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. 2015;372:1589–97.CrossRefPubMed
5.
De Vlaminck I, Valantine HA, Snyder TM, Strehl C, Cohen G, Luikart H, Neff NF, Okamoto J, Bernstein D, Weisshaar D, Quake SR, Khush KK. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med. 2014;6:241ra277.CrossRef
6.
Shoham Y, Krieger Y, Perry ZH, Shaked G, Bogdanov-Berezovsky A, Silberstein E, Sagi A, Douvdevani A. Admission cell free DNA as a prognostic factor in burns: quantification by use of a direct rapid fluorometric technique. Biomed Res Int. 2014;2014:306580.CrossRefPubMedPubMedCentral
7.
Avriel A, Paryente Wiessman M, Almog Y, Perl Y, Novack V, Galante O, Klein M, Pencina MJ, Douvdevani A. Admission cell free DNA levels predict 28-day mortality in patients with severe sepsis in intensive care. PLoS One. 2014;9:e100514.CrossRefPubMedPubMedCentral
8.
Garnacho-Montero J, Huici-Moreno MJ, Gutierrez-Pizarraya A, Lopez I, Marquez-Vacaro JA, Macher H, Guerrero JM, Puppo-Moreno A. Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis. Crit Care. 2014;18:R116.CrossRefPubMedPubMedCentral
9.
Spindler KL, Pallisgaard N, Appelt AL, Andersen RF, Schou JV, Nielsen D, Pfeiffer P, Yilmaz M, Johansen JS, Hoegdall EV, Jakobsen A, Jensen BV. Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti-epidermal growth factor receptor therapy. Eur J Cancer. 2015;51:2678–85.CrossRefPubMed
10.
Spindler KL, Appelt AL, Pallisgaard N, Andersen RF, Brandslund I, Jakobsen A. Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer. Int J Cancer. 2014;135:2984–91.CrossRefPubMed
11.
Spindler KL, Pallisgaard N, Andersen RF, Brandslund I, Jakobsen A. Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer. PLoS One. 2015;10:e0108247.CrossRefPubMedPubMedCentral
12.
Fournie G, Courtin J, Laval F, Chalé J, Pourrat J, Pujazon M, Laugue D, Carles P. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett. 1995;91:221–7.CrossRefPubMed
13.
Fournie G, Martres F, Pourrat J, Alary C, Rumeau M. Plasma DNA as cell death marker in elderly patients. Gerontology. 1993;39:215–21.CrossRefPubMed
14.
Lo YMD, Rainer TH, Chan LYS, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem. 2000;46:319–23.PubMed
15.
Margraf S, Lögters T, Reipen J, Altrichter J, Scholz M, Windolf J. Neutrophil-derived circulating free DNA (CF-DNA/NETS): a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis. Shock. 2008;30:352–8.CrossRefPubMed
16.
Wang H-C, Lin Y-J, Tsai N-W, Su BY-J, Kung C-T, Chen W-F, Kwan A-L, Lu C-H. Serial plasma deoxyribonucleic acid levels as predictors of outcome in acute traumatic brain injury. J Neurotrauma. 2014;31:1039–45.CrossRefPubMed
17.
Diehl F, Schmidt K, Choti M, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo S, Kinzler K, Vogelstein B, Diaz LJ. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14:985–90.CrossRefPubMed
18.
Rubartelli A, Lotze M. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 2007;28:429–36.CrossRefPubMed
19.
Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104–7.CrossRefPubMedPubMedCentral
20.
21.
El Messaoudi S, Rolet F, Mouliere F, Thierry AR. Circulating cell free DNA: preanalytical considerations. Clin Chim Acta. 2013;424:222–30.CrossRefPubMed
22.
23.
Rainer TH, Chan AK, Lee LL, Yim VW, Lam NY, Yeung SW, Graham CA, Lo DY. Use of plasma DNA to predict mortality and need for intensive care in patients with abdominal pain. Clin Chim Acta. 2008;398:113–7.CrossRefPubMed
24.
Rainer TH, Lam NY, Man CY, Chiu RW, Woo KS, Lo YM. Plasma beta-globin DNA as a prognostic marker in chest pain patients. Clin Chim Acta. 2006;368:110–3.CrossRefPubMed
25.
Potenza L, Calcabrini C, Bellis RD, Mancini U, Polidori E, Zeppa S, Alloni R, Cucchiarini L, Dacha M. Effect of surgical stress on nuclear and mitochondrial DNA from healthy sections of colon and rectum of patients with colorectal cancer. J Biosci. 2011;36:243–51.CrossRefPubMed
26.
Levy M, Benesova L, Lipska L, Belsanova B, Minarikova P, Veprekova G, Zavoral M, Minarik M. Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients. Anticancer Res. 2012;32:1621–6.PubMed
27.
Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, Lawler LA, Christie JD, Meyer NJ, Mc Causland FR, Waikar SS, Waxman AB, Chung RT, Bueno R, Rosas IO, Fredenburgh LE, Baron RM, Christiani DC, Hunninghake GM, Choi AM. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013;10:e1001577. discussion e1001577.CrossRefPubMedPubMedCentral
28.
Saukkonen K, Lakkisto P, Varpula M, Varpula T, Voipio-Pulkki LM, Pettila V, Pulkki K. Association of cell-free plasma DNA with hospital mortality and organ dysfunction in intensive care unit patients. Intensive Care Med. 2007;33:1624–7.CrossRefPubMed
29.
Lam NYL, Rainer TH, Chan LYS, Joynt GM, Lo YMD. Time course of early and late changes in plasma DNA in trauma patients. Clin Chem. 2003;49:1286–91.CrossRefPubMed
30.
Macher H, Egea-Guerrero JJ, Revuelto-Rey J, Gordillo-Escobar E, Enamorado-Enamorado J, Boza A, Rodriguez A, Molinero P, Guerrero JM, Dominguez-Roldán JM, Murillo-Cabezas F, Rubio A. Role of early cell-free DNA levels decrease as a predictive marker of fatal outcome after severe traumatic brain injury. Clin Chim Acta. 2012;414:12–7.CrossRefPubMed
31.
Shaked G, Douvdevani A, Yair S, Zlotnik A, Czeiger D. The role of cell-free DNA measured by a fluorescent test in the management of isolated traumatic head injuries. Scand J Trauma Resusc Emerg Med. 2014;22: doi:10.​1186/​1757-7241-1122-1121.
32.
Yurgel VC, Ikuta N, Rocha ABD, Lunge VR, Schneider RF, Fonseca ASK, Grivicich I, Zanoni C, Regner A. Role of plasma DNA as a predictive marker of fatal outcome following severe head injury in males. J Neurotrauma. 2007;24:1172–81.CrossRef
33.
Filho EMR, Simon D, Ikuta N, Klovan C, Dannebrock FA, Oliveira CO, Regner A. Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury. J Neurotrauma. 2014;31:1639–46.CrossRef
34.
Yamanouchi S, Kudo D, Yamada M, Miyagawa N, Furukawa H, Kushimoto S. Plasma mitochondrial DNA levels in patients with trauma and severe sepsis: time course and the association with clinical status. J Crit Care. 2013;28:1027–31.CrossRefPubMed
35.
Gu X, Yao Y, Wu G, Lv T, Luo L, Song Y. The plasma mitochondrial DNA is an independent predictor for post-traumatic systemic inflammatory response syndrome. Plos One. 2013;8:e72834.CrossRefPubMedPubMedCentral
36.
Lam NY, Rainer TH, Chiu RW, Joynt GM, Lo YM. Plasma mitochondrial DNA concentrations after trauma. Clin Chem. 2004;50:213–6.CrossRefPubMed
37.
Ren B, Liu F, Xu F, He J, Zhu H, Zou G. Is plasma cell-free DNA really a useful marker for diagnosis and treatment of trauma patients? Clin Chim Acta. 2013;424:109–13.CrossRefPubMed
38.
McIlroy DJ, Bigland M, White AE, Hardy BM, Lott N, Smith DW, Balogh ZJ. Cell necrosis-independent sustained mitochondrial and nuclear DNA release following trauma surgery. J Trauma Acute Care Surg. 2015;78:282–8.CrossRefPubMedPubMedCentral
39.
Wijeratne S, Butt A, Burns S, Sherwood K, Boyd O, Swaminathan R. Cell-free plasma DNA as a prognostic marker in intensive treatment unit patients. Ann N Y Acad Sci. 2004;1022:232–8.CrossRefPubMed
40.
Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED. Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care. 2006;10:R60.CrossRefPubMedPubMedCentral
41.
Dwidevi DJ, Toltl LJ, Swystun LL, et al. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care. 2012;16:R151.CrossRef
42.
Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, Lopez MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, Calvano SE, McDonald-Smith GP, Schoenfeld DA, Storey JD, Cobb JP, Warren HS, Moldawer LL, Herndon DN, Lowry SF, Maier RV, Davis RW, Tompkins RG, Inflammation, Host Response to Injury Large-Scale Collaborative Research P. A genomic storm in critically injured humans. J Exp Med. 2011;208:2581–90.CrossRefPubMedPubMedCentral
43.
McIlroy DJ, Jarnicki AG, Au GG, Lott N, Smith DW, Hansbro PM, Balogh ZJ. Mitochondrial DNA neutrophil extracellular traps are formed after trauma and subsequent surgery. J Crit Care. 2014;29:1133. e1131-1135.CrossRefPubMed
44.
Timmermanns K, Kox M, Vaneker M, Berg M, John A, Laarhoven A, Hoeven H, Scheffer GJ, Pickkers P. Plasma levels of danger-associated molecular patterns are associated with immune suppression in trauma patients. Intensive Care Med. 2016;42:551–61.CrossRef
Metadata
Title
The role of total cell-free DNA in predicting outcomes among trauma patients in the intensive care unit: a systematic review
Authors
Mikail Gögenur
Jakob Burcharth
Ismail Gögenur
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2017
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-016-1578-9

Other articles of this Issue 1/2017

Critical Care 1/2017 Go to the issue

Erratum

Erratum to: Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside

Research

Prognostic value of platelet-to-lymphocyte ratios among critically ill patients with acute kidney injury

Review

Novel insights in ICU-acquired respiratory muscle dysfunction: implications for clinical care

Letter

Subclavian oblique-axis catheterization technique

Research

Outcomes of subsyndromal delirium in ICU: a systematic review and meta-analysis

Review

High-flow nasal cannula support therapy: new insights and improving performance